Ferric Citrate Tablets(Ref,Brand: Auryxia(US), Ferrozan(EU) Generics

Form: Tablet

Strength: 210 mg, 500mg

Reference Brands:

Category: Nephrology

Ferric Citrate Tablets are an essential nephrology therapy for managing hyperphosphatemia and anemia in chronic kidney disease (CKD). As a dual‑action phosphate binder and oral iron supplement, ferric citrate reduces serum phosphate levels while delivering bioavailable iron to support erythropoiesis. Marketed as Auryxia® in the US and Ferrozan® in the EU, these tablets streamline CKD care by replacing separate phosphate binders and iron supplements. Ideal for Pharma B2B distributors and hospital procurement, our bulk supply meets FDA and EMA standards, offering cost‑effective renal care solutions. Boost your portfolio with high‑quality Ferric Citrate Tablets for global renal therapy markets.